Report Overview
Serum procalcitonin is a biomarker used in the medical field to aid in the diagnosis of bacterial infections and sepsis. It is a precursor hormone to calcitonin and is produced by various tissues in response to bacterial infections, making it a valuable tool for healthcare professionals in determining the presence and severity of such infections. By measuring the levels of procalcitonin in the blood, clinicians can make more informed decisions regarding the initiation or discontinuation of antibiotics, thereby helping to improve patient outcomes and reduce the misuse of antibiotics.
The market for serum procalcitonin is experiencing significant growth due to several key factors. One of the primary market drivers is the increasing prevalence of sepsis and other bacterial infections worldwide. With the rise of antibiotic resistance, there is a growing need for more accurate and timely diagnostic tools to differentiate between bacterial and viral infections. Serum procalcitonin has shown promising results in this regard, driving its adoption in clinical settings. Additionally, the shift towards value-based healthcare and the emphasis on reducing healthcare costs are further fueling the demand for biomarkers like procalcitonin that can help optimize treatment decisions and improve patient outcomes.
In addition to the increasing demand for serum procalcitonin in the healthcare industry, technological advancements in diagnostic testing methods are also contributing to the market growth. The development of rapid and automated procalcitonin assays has made it easier for healthcare providers to measure procalcitonin levels quickly and accurately, leading to more efficient decision-making processes. Moreover, the growing awareness among healthcare professionals about the benefits of using procalcitonin as a biomarker for bacterial infections is expected to drive further market expansion in the coming years.
The global Serum Procalcitonin market size was estimated at USD 1.48 million in 2024 and is projected to reach USD 1.48 million by 2033, exhibiting a CAGR of 0 during the forecast period.
This report provides a deep insight into the global Serum Procalcitonin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Serum Procalcitonin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Serum Procalcitonin market in any manner.
Global Serum Procalcitonin Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Market Segmentation (by Type)
Procalcitonin Antigen
Procalcitonin Antibody
Market Segmentation (by Application)
Medical Industry
Scientific Research
Veterinarian
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Serum Procalcitonin Market
- Overview of the regional outlook of the Serum Procalcitonin Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Serum Procalcitonin Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Serum Procalcitonin, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Table of Contents 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Serum Procalcitonin 1.2 Key Market Segments 1.2.1 Serum Procalcitonin Segment by Type 1.2.2 Serum Procalcitonin Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Serum Procalcitonin Market Overview 2.1 Global Market Overview 2.1.1 Global Serum Procalcitonin Market Size (M USD) Estimates and Forecasts (2020-2033) 2.1.2 Global Serum Procalcitonin Sales Estimates and Forecasts (2020-2033) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Serum Procalcitonin Market Competitive Landscape 3.1 Company Assessment Quadrant 3.2 Global Serum Procalcitonin Product Life Cycle 3.3 Global Serum Procalcitonin Sales by Manufacturers (2020-2025) 3.4 Global Serum Procalcitonin Revenue Market Share by Manufacturers (2020-2025) 3.5 Serum Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Serum Procalcitonin Average Price by Manufacturers (2020-2025) 3.7 Manufacturers Serum Procalcitonin Sales Sites, Area Served, Product Type 3.8 Serum Procalcitonin Market Competitive Situation and Trends 3.8.1 Serum Procalcitonin Market Concentration Rate 3.8.2 Global 5 and 10 Largest Serum Procalcitonin Players Market Share by Revenue 3.8.3 Mergers & Acquisitions, Expansion 4 Serum Procalcitonin Industry Chain Analysis 4.1 Serum Procalcitonin Industry Chain Analysis 4.2 Market Overview of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Serum Procalcitonin Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 PEST Analysis 5.6.1 Industry Policies Analysis 5.6.2 Economic Environment Analysis 5.6.3 Social Environment Analysis 5.6.4 Technological Environment Analysis 5.7 Global Serum Procalcitonin Market Porter's Five Forces Analysis 5.7.1 Global Trade Frictions 5.7.2 Global Trade Frictions and Their Impacts to Serum Procalcitonin Market 5.8 ESG Ratings of Leading Companies 6 Serum Procalcitonin Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Serum Procalcitonin Sales Market Share by Type (2020-2025) 6.3 Global Serum Procalcitonin Market Size Market Share by Type (2020-2025) 6.4 Global Serum Procalcitonin Price by Type (2020-2025) 7 Serum Procalcitonin Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Serum Procalcitonin Market Sales by Application (2020-2025) 7.3 Global Serum Procalcitonin Market Size (M USD) by Application (2020-2025) 7.4 Global Serum Procalcitonin Sales Growth Rate by Application (2020-2025) 8 Serum Procalcitonin Market Sales by Region 8.1 Global Serum Procalcitonin Sales by Region 8.1.1 Global Serum Procalcitonin Sales by Region 8.1.2 Global Serum Procalcitonin Sales Market Share by Region 8.2 Global Serum Procalcitonin Market Size by Region 8.2.1 Global Serum Procalcitonin Market Size by Region 8.2.2 Global Serum Procalcitonin Market Size Market Share by Region 8.3 North America 8.3.1 North America Serum Procalcitonin Sales by Country 8.3.2 North America Serum Procalcitonin Market Size by Country 8.3.3 U.S. Market Overview 8.3.4 Canada Market Overview 8.3.5 Mexico Market Overview 8.4 Europe 8.4.1 Europe Serum Procalcitonin Sales by Country 8.4.2 Europe Serum Procalcitonin Market Size by Country 8.4.3 Germany Market Overview 8.4.4 France Market Overview 8.4.5 U.K. Market Overview 8.4.6 Italy Market Overview 8.4.7 Spain Market Overview 8.5 Asia Pacific 8.5.1 Asia Pacific Serum Procalcitonin Sales by Region 8.5.2 Asia Pacific Serum Procalcitonin Market Size by Region 8.5.3 China Market Overview 8.5.4 Japan Market Overview 8.5.5 South Korea Market Overview 8.5.6 India Market Overview 8.5.7 Southeast Asia Market Overview 8.6 South America 8.6.1 South America Serum Procalcitonin Sales by Country 8.6.2 South America Serum Procalcitonin Market Size by Country 8.6.3 Brazil Market Overview 8.6.4 Argentina Market Overview 8.6.5 Columbia Market Overview 8.7 Middle East and Africa 8.7.1 Middle East and Africa Serum Procalcitonin Sales by Region 8.7.2 Middle East and Africa Serum Procalcitonin Market Size by Region 8.7.3 Saudi Arabia Market Overview 8.7.4 UAE Market Overview 8.7.5 Egypt Market Overview 8.7.6 Nigeria Market Overview 8.7.7 South Africa Market Overview 9 Serum Procalcitonin Market Production by Region 9.1 Global Production of Serum Procalcitonin by Region(2020-2025) 9.2 Global Serum Procalcitonin Revenue Market Share by Region (2020-2025) 9.3 Global Serum Procalcitonin Production, Revenue, Price and Gross Margin (2020-2025) 9.4 North America Serum Procalcitonin Production 9.4.1 North America Serum Procalcitonin Production Growth Rate (2020-2025) 9.4.2 North America Serum Procalcitonin Production, Revenue, Price and Gross Margin (2020-2025) 9.5 Europe Serum Procalcitonin Production 9.5.1 Europe Serum Procalcitonin Production Growth Rate (2020-2025) 9.5.2 Europe Serum Procalcitonin Production, Revenue, Price and Gross Margin (2020-2025) 9.6 Japan Serum Procalcitonin Production (2020-2025) 9.6.1 Japan Serum Procalcitonin Production Growth Rate (2020-2025) 9.6.2 Japan Serum Procalcitonin Production, Revenue, Price and Gross Margin (2020-2025) 9.7 China Serum Procalcitonin Production (2020-2025) 9.7.1 China Serum Procalcitonin Production Growth Rate (2020-2025) 9.7.2 China Serum Procalcitonin Production, Revenue, Price and Gross Margin (2020-2025) 10 Key Companies Profile 10.1 Thermo Fisher 10.1.1 Thermo Fisher Basic Information 10.1.2 Thermo Fisher Serum Procalcitonin Product Overview 10.1.3 Thermo Fisher Serum Procalcitonin Product Market Performance 10.1.4 Thermo Fisher Business Overview 10.1.5 Thermo Fisher SWOT Analysis 10.1.6 Thermo Fisher Recent Developments 10.2 Roche Diagnostics 10.2.1 Roche Diagnostics Basic Information 10.2.2 Roche Diagnostics Serum Procalcitonin Product Overview 10.2.3 Roche Diagnostics Serum Procalcitonin Product Market Performance 10.2.4 Roche Diagnostics Business Overview 10.2.5 Roche Diagnostics SWOT Analysis 10.2.6 Roche Diagnostics Recent Developments 10.3 bioMerieux 10.3.1 bioMerieux Basic Information 10.3.2 bioMerieux Serum Procalcitonin Product Overview 10.3.3 bioMerieux Serum Procalcitonin Product Market Performance 10.3.4 bioMerieux Business Overview 10.3.5 bioMerieux SWOT Analysis 10.3.6 bioMerieux Recent Developments 10.4 HyTest 10.4.1 HyTest Basic Information 10.4.2 HyTest Serum Procalcitonin Product Overview 10.4.3 HyTest Serum Procalcitonin Product Market Performance 10.4.4 HyTest Business Overview 10.4.5 HyTest Recent Developments 10.5 BBI Solutions 10.5.1 BBI Solutions Basic Information 10.5.2 BBI Solutions Serum Procalcitonin Product Overview 10.5.3 BBI Solutions Serum Procalcitonin Product Market Performance 10.5.4 BBI Solutions Business Overview 10.5.5 BBI Solutions Recent Developments 10.6 ProSpec 10.6.1 ProSpec Basic Information 10.6.2 ProSpec Serum Procalcitonin Product Overview 10.6.3 ProSpec Serum Procalcitonin Product Market Performance 10.6.4 ProSpec Business Overview 10.6.5 ProSpec Recent Developments 10.7 Wondfo 10.7.1 Wondfo Basic Information 10.7.2 Wondfo Serum Procalcitonin Product Overview 10.7.3 Wondfo Serum Procalcitonin Product Market Performance 10.7.4 Wondfo Business Overview 10.7.5 Wondfo Recent Developments 10.8 Ningbo Medicalsystem Biotechnology 10.8.1 Ningbo Medicalsystem Biotechnology Basic Information 10.8.2 Ningbo Medicalsystem Biotechnology Serum Procalcitonin Product Overview 10.8.3 Ningbo Medicalsystem Biotechnology Serum Procalcitonin Product Market Performance 10.8.4 Ningbo Medicalsystem Biotechnology Business Overview 10.8.5 Ningbo Medicalsystem Biotechnology Recent Developments 10.9 Wuhan Easy Diagnosis Biomedicine 10.9.1 Wuhan Easy Diagnosis Biomedicine Basic Information 10.9.2 Wuhan Easy Diagnosis Biomedicine Serum Procalcitonin Product Overview 10.9.3 Wuhan Easy Diagnosis Biomedicine Serum Procalcitonin Product Market Performance 10.9.4 Wuhan Easy Diagnosis Biomedicine Business Overview 10.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments 10.10 Snibe 10.10.1 Snibe Basic Information 10.10.2 Snibe Serum Procalcitonin Product Overview 10.10.3 Snibe Serum Procalcitonin Product Market Performance 10.10.4 Snibe Business Overview 10.10.5 Snibe Recent Developments 10.11 Vazyme Biotech 10.11.1 Vazyme Biotech Basic Information 10.11.2 Vazyme Biotech Serum Procalcitonin Product Overview 10.11.3 Vazyme Biotech Serum Procalcitonin Product Market Performance 10.11.4 Vazyme Biotech Business Overview 10.11.5 Vazyme Biotech Recent Developments 10.12 Getein Biotech 10.12.1 Getein Biotech Basic Information 10.12.2 Getein Biotech Serum Procalcitonin Product Overview 10.12.3 Getein Biotech Serum Procalcitonin Product Market Performance 10.12.4 Getein Biotech Business Overview 10.12.5 Getein Biotech Recent Developments 10.13 Hotgen Biotech 10.13.1 Hotgen Biotech Basic Information 10.13.2 Hotgen Biotech Serum Procalcitonin Product Overview 10.13.3 Hotgen Biotech Serum Procalcitonin Product Market Performance 10.13.4 Hotgen Biotech Business Overview 10.13.5 Hotgen Biotech Recent Developments 10.14 Lumigenex 10.14.1 Lumigenex Basic Information 10.14.2 Lumigenex Serum Procalcitonin Product Overview 10.14.3 Lumigenex Serum Procalcitonin Product Market Performance 10.14.4 Lumigenex Business Overview 10.14.5 Lumigenex Recent Developments 10.15 Nanjing Norman Biological Technology 10.15.1 Nanjing Norman Biological Technology Basic Information 10.15.2 Nanjing Norman Biological Technology Serum Procalcitonin Product Overview 10.15.3 Nanjing Norman Biological Technology Serum Procalcitonin Product Market Performance 10.15.4 Nanjing Norman Biological Technology Business Overview 10.15.5 Nanjing Norman Biological Technology Recent Developments 10.16 Kitgen 10.16.1 Kitgen Basic Information 10.16.2 Kitgen Serum Procalcitonin Product Overview 10.16.3 Kitgen Serum Procalcitonin Product Market Performance 10.16.4 Kitgen Business Overview 10.16.5 Kitgen Recent Developments 10.17 Beijing KeyGen 10.17.1 Beijing KeyGen Basic Information 10.17.2 Beijing KeyGen Serum Procalcitonin Product Overview 10.17.3 Beijing KeyGen Serum Procalcitonin Product Market Performance 10.17.4 Beijing KeyGen Business Overview 10.17.5 Beijing KeyGen Recent Developments 10.18 Beijing Apis 10.18.1 Beijing Apis Basic Information 10.18.2 Beijing Apis Serum Procalcitonin Product Overview 10.18.3 Beijing Apis Serum Procalcitonin Product Market Performance 10.18.4 Beijing Apis Business Overview 10.18.5 Beijing Apis Recent Developments 11 Serum Procalcitonin Market Forecast by Region 11.1 Global Serum Procalcitonin Market Size Forecast 11.2 Global Serum Procalcitonin Market Forecast by Region 11.2.1 North America Market Size Forecast by Country 11.2.2 Europe Serum Procalcitonin Market Size Forecast by Country 11.2.3 Asia Pacific Serum Procalcitonin Market Size Forecast by Region 11.2.4 South America Serum Procalcitonin Market Size Forecast by Country 11.2.5 Middle East and Africa Forecasted Sales of Serum Procalcitonin by Country 12 Forecast Market by Type and by Application (2026-2033) 12.1 Global Serum Procalcitonin Market Forecast by Type (2026-2033) 12.1.1 Global Forecasted Sales of Serum Procalcitonin by Type (2026-2033) 12.1.2 Global Serum Procalcitonin Market Size Forecast by Type (2026-2033) 12.1.3 Global Forecasted Price of Serum Procalcitonin by Type (2026-2033) 12.2 Global Serum Procalcitonin Market Forecast by Application (2026-2033) 12.2.1 Global Serum Procalcitonin Sales (K MT) Forecast by Application 12.2.2 Global Serum Procalcitonin Market Size (M USD) Forecast by Application (2026-2033) 13 Conclusion and Key Findings
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook